A research project at Emory University is among the 22 grants and contracts that are being cancelled as the U.S. Department of Health and Human Services begins a “coordinated wind-down” of research studying mRNA vaccine technology.
Hungarian-born biochemist Katalin Karikó and American immunologist Drew Weissman found that a chemical change to genetic code called mRNA eliminated a problematic side effect when used in vaccines.
During the pandemic scientists launched a vaccine in record-breaking time. Their successful use of mRNA technology could lead to progress in the decades-long effort for an HIV inoculation.
